Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOLOGY
Volume 197, Issue 12, Pages 4603-4612
Publisher
The American Association of Immunologists
Online
2016-11-10
DOI
10.4049/jimmunol.1601197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control
- (2016) Margaret E. Ackerman et al. PLoS Pathogens
- Passively Acquired Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity in HIV-Infected Infants Is Associated with Reduced Mortality
- (2015) Caitlin Milligan et al. Cell Host & Microbe
- Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
- (2015) D. H. Barouch et al. SCIENCE
- Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life
- (2015) Austin W. Boesch et al. Current Opinion in HIV and AIDS
- Antigenic Properties of the Human Immunodeficiency Virus Envelope Glycoprotein Gp120 on Virions Bound to Target Cells
- (2015) Meron Mengistu et al. PLoS Pathogens
- Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
- (2014) Stylianos Bournazos et al. CELL
- FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
- (2014) Shuying S. Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials
- (2014) Anna Sambor et al. JOURNAL OF IMMUNOLOGICAL METHODS
- HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral Activities
- (2014) Justin Pollara et al. JOURNAL OF VIROLOGY
- Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
- (2014) A. W. Chung et al. Science Translational Medicine
- Epitope target structures of Fc-mediated effector function during HIV-1 acquisition
- (2014) George K. Lewis et al. Current Opinion in HIV and AIDS
- Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys
- (2013) Dan H. Barouch et al. CELL
- Opportunities to Exploit Non-Neutralizing HIV-Specific Antibody Activity
- (2013) Margaret Ackerman et al. CURRENT HIV RESEARCH
- Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
- (2013) Hua-Xin Liao et al. IMMUNITY
- Role of Fc-mediated antibody function in protective immunity against HIV-1
- (2013) George K. Lewis IMMUNOLOGY
- Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity
- (2013) Margaret E. Ackerman et al. JOURNAL OF CLINICAL INVESTIGATION
- Enhanced Phagocytic Activity of HIV-Specific Antibodies Correlates with Natural Production of Immunoglobulins with Skewed Affinity for Fc R2a and Fc R2b
- (2013) M. E. Ackerman et al. JOURNAL OF VIROLOGY
- Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
- (2013) G. D. Tomaras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection
- (2012) Leia H. Wren et al. IMMUNOLOGY
- Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
- (2012) M. Bonsignori et al. JOURNAL OF VIROLOGY
- A Nonfucosylated Variant of the anti-HIV-1 Monoclonal Antibody b12 Has Enhanced Fc RIIIa-Mediated Antiviral Activity In Vitro but Does Not Improve Protection against Mucosal SHIV Challenge in Macaques
- (2012) B. Moldt et al. JOURNAL OF VIROLOGY
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of Cytokines on HIV-Specific Antibody-Dependent Cellular Cytotoxicity Activation Profile of Natural Killer Cells
- (2012) Leia Wren et al. PLoS One
- Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding
- (2012) Y. Guan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral Loads
- (2012) Jennifer Mabuka et al. PLoS Pathogens
- High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses
- (2011) Justin Pollara et al. CYTOMETRY PART A
- Activation of NK Cells by ADCC Antibodies and HIV Disease Progression
- (2011) Amy W Chung et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A Panel of IgG1 b12 Variants with Selectively Diminished or Enhanced Affinity for Fc Receptors To Define the Role of Effector Functions in Protection against HIV
- (2011) B. Moldt et al. JOURNAL OF VIROLOGY
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
- (2010) Margaret E. Ackerman et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC
- (2010) Tara G. Edmonds et al. VIROLOGY
- Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy
- (2008) Florencia Pereyra et al. JOURNAL OF INFECTIOUS DISEASES
- Role of Particle Size in Phagocytosis of Polymeric Microspheres
- (2008) Julie A. Champion et al. PHARMACEUTICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started